Pregablin 75 mg Capsule

Adult dose

This medication should be taken orally, divided into two doses per day without regard to meals. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose is 150 mg per day, can be increased to 300 mg per day in 3 to 7 days, may be further increased to a maximum of 600 mg per day at intervals of 7 days if necessary. - Central Neuropathic Pain: Starting dose is 150 mg per day, can be increased to 300 mg per day after 1 week.

Child dose

The safety and efficacy data for children under 12 years of age and adolescents aged 12 to 17 years are insufficient, so administration is not recommended.

This drug may increase the risk of suicidal thoughts and behaviors; therefore, if mood changes or abnormal behavior occur during treatment, you should immediately inform your healthcare provider. You should not take this medication if you are allergic to any of its components or have specific genetic issues such as lactose intolerance. Diabetic patients may need to adjust the dosage of blood sugar control medications due to weight gain. If allergic reactions, such as angioedema, occur, you must stop taking this medication immediately and observe for symptoms like swelling of the face or around the mouth. Elderly patients may experience side effects such as dizziness, drowsiness, or loss of consciousness, so caution is warranted, and care should be taken if these symptoms occur. Transient blurriness of vision or changes in eyesight may occur; if these symptoms arise, consult your healthcare provider. When discontinuing this medication, withdrawal symptoms such as insomnia, headaches, or anxiety may appear; hence, it is advisable to gradually reduce the dosage under the guidance of a healthcare provider. There is a risk of drug abuse; hence, patients with a history of substance abuse or mental disorders should exercise considerable caution. Patients with decreased kidney function may require dosage adjustments, and improvement in kidney function may necessitate stopping or reducing the medication. Patients with cardiovascular diseases should be cautious when taking this medication. Care should be taken when this medication is used in conjunction with other CNS depressants or opioid analgesics because of the risk of respiratory depression. During early pregnancy, there is a risk of fetal malformations; therefore, women who are pregnant or planning to become pregnant must consult their healthcare provider and use effective contraceptive methods. During breastfeeding, this medication may be passed into breast milk and affect infants. Therefore, consult your healthcare provider regarding breastfeeding while taking this medication. Dizziness and drowsiness are common; therefore, it is advisable to avoid driving or operating dangerous machinery while taking this drug. In cases of overdose, symptoms such as confusion, drowsiness, depression, and seizures may occur, and urgent medical attention is required. Keep out of reach of children and take care not to transfer to other containers.

Serious side effects

Hives, severe swelling, angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, peeling skin, oral/ocular mucosal pain, severe skin reactions, asthma attacks, respiratory anomalies accompanied by cough and fever, shortness of breath or difficulty breathing, pulmonary edema, respiratory depression, yellowing of the skin or eyes, jaundice, extreme lethargy, liver problems, sudden

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain the storage temperature between 15 and 30 degrees Celsius.

Appearance

Brownish-yellow hard capsule with white powder inside

Package unit

30 capsules/bottle, 60 capsules/bottle